Stem definition | Drug id | CAS RN |
---|---|---|
4361 | 474-25-9 |
Dose | Unit | Route |
---|---|---|
1 | g | O |
Property | Value | Reference |
---|---|---|
Vd (Volume of distribution) | 0.19 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 5.70 mL/min/kg | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 1.42 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
July 28, 1983 | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | A05AA01 | ALIMENTARY TRACT AND METABOLISM BILE AND LIVER THERAPY BILE THERAPY Bile acids and derivatives |
MeSH PA | D002400 | Cathartics |
MeSH PA | D005765 | Gastrointestinal Agents |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Calculus in biliary tract | indication | 266474003 | |
Hypercholesterolemia | contraindication | 13644009 | |
Obstruction of bile duct | contraindication | 30144000 | |
Primary biliary cirrhosis | contraindication | 31712002 | DOID:12236 |
Diarrhea | contraindication | 62315008 | |
Liver function tests abnormal | contraindication | 166603001 | |
Disease of liver | contraindication | 235856003 | DOID:409 |
Sclerosing cholangitis | contraindication | 235917005 | DOID:14268 |
Pregnancy, function | contraindication | 289908002 | |
Gallstone Complications | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.92 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Bile acid receptor | Nuclear hormone receptor | AGONIST | EC50 | 5.47 | CHEMBL | CHEMBL | |||
fMet-Leu-Phe receptor | GPCR | ANTAGONIST | Ki | 4 | IUPHAR | ||||
G-protein coupled bile acid receptor 1 | GPCR | AGONIST | EC50 | 5.40 | IUPHAR |
ID | Source |
---|---|
0GEI24LG0J | UNII |
4022365 | VUID |
D00163 | KEGG_DRUG |
N0000146754 | NUI |
4018428 | VANDF |
4022365 | VANDF |
C0008024 | UMLSCUI |
CHEBI:16755 | CHEBI |
JN3 | PDB_CHEM_ID |
CHEMBL240597 | ChEMBL_ID |
10133 | PUBCHEM_CID |
DB06777 | DRUGBANK_ID |
4391 | INN_ID |
608 | IUPHAR_LIGAND_ID |
2323 | RXNORM |
25632 | MMSL |
d07268 | MMSL |
001208 | NDDF |
82490009 | SNOMEDCT_US |
89132005 | SNOMEDCT_US |
D002635 | MESH_DESCRIPTOR_UI |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Chenodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0722-7121 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 19 sections |
Chenodal | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45043-876 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 18 sections |
Chenodal | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68974-876 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 20 sections |
Chenodal | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68974-876 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 20 sections |
Chenodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 79739-7121 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 19 sections |
Chenodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 79739-7121 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 19 sections |